PER 2.67% 7.3¢ percheron therapeutics limited

From the AGM preso Dec2020... ....As reported, the recent...

  1. 4,683 Posts.
    lightbulb Created with Sketch. 1086
    From the AGM preso Dec2020...

    ....As reported, the recent financing has provided capital to support the preparatory work for the trial up to trial initiation, therefore the major costs associated with the conduct of the trial are not anticipated to come through until later in 2021. In the interim, the company will look at funding options for the trial while continuing with its planned corporate engagement which may present as part of the financing option.

    .
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.